Off-label drug use in childhood asthma
Date
2011
Authors
Kling S.
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Off-label prescribing means unlabelled or unap-proved prescribing of a registered medicine for a use that is not included in the product information, such as for a different indication, age, dose or dosing regimen, or via a different route. An unregistered or unlicensed medicine in South Africa is one that has not been assessed or approved by the Medicines Control Council (MCC). Off-label prescribing is relatively common in children, and many anti-asthmatic drugs are used off-label, particularly in young children. Off-label prescribing is not illegal and is not necessarily wrong. It is a refection of inadequate paediatric clinical trials. The main problems with off-label prescribing are the higher rate of adverse events and ethical issues such as benefit/ harm risks and the need for informed consent. The MCC should facilitate the registration of drugs for paediatric use, and should both enforce and encourage drug trials for medicines for children.
Description
Keywords
Citation
Current Allergy and Clinical Immunology
24
1
38
41
24
1
38
41